Evidence map›Paper›PMID 25381027›Full record

ReviewAmerican journal of physiology. Lung cellular and molecular physiology2014

CFTR and lung homeostasis.

James F Collawn, Sadis Matalon

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Lung cellular and molecular physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05392855 (Symptom Based Performance of Airway Clearance Therapy After Starting Highly Effective CFTR Modulator Therapy for Cystic Fibrosis), which is not on this map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05392855 naterminatednot on this mapstarted 2023, after this paper: background citation

Symptom Based Performance of Airway Clearance Therapy After Starting Highly Effective CFTR Modulator Therapy for Cystic Fibrosis

TypeinterventionalSponsorUniversity of Missouri-ColumbiaRan2023 to 2024Enrolled6ConditionsCystic Fibrosis, Mucociliary Clearance DefectArmsSymptom driven performance of airway clearance, Continuous daily performance of airway clearance
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 89 citations in OpenAlex.

  1. Trial
  2. Article
  3. Mesenchymal stromal cell extracellular vesicles reduceAmerican journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  4. Let-7b-5p loaded Mesenchymal Stromal Cell Extracellular Vesicles reducebioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. TRPV4 Channel Modulators as Potential Drug Candidates for Cystic Fibrosis.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Extracellular vesicles secreted by primary human bronchial epithelial cells reduceAmerican journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  12. Vaping-Induced Proteolysis Causes Airway Surface Dehydration.International journal of molecular sciences · 2023
    Article
  13. Review
  14. KBiomedicines · 2023
    Review
  15. Article
  16. Review
  17. ACS pharmacology & translational science · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

James F CollawnDepartment of Cell, Developmental and Integrative Biology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Pulmonary Injury and Repair Center, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; and Gregory Fleming James Cystic Fibrosis Center, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama jcollawn@uab.edu.
Sadis MatalonDepartment of Anesthesiology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Cell, Developmental and Integrative Biology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Pulmonary Injury and Repair Center, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; and Gregory Fleming James Cystic Fibrosis Center, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
University of Alabama at Birmingham · US

Funding

PATHOPHYSIOLOGY OF SUBLETHAL OXYGEN IN INJURED LUNGSR01HL031197 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MARK N GILLESPIE, Sadis Matalon · 1985 to 2026
$4.2M
Cell Biology of CFTR in Polarized EpitheliaR01DK060065 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI COLLAWN, JAMES F. · 2003 to 2013
$3.1M
Central Role of Heme Oxygenase in Reversing Bromine Morbidity and MortalityR21ES025423 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM, MATALON, SADIS · 2014 to 2015
$771k
Mitochondrial Bioenergetic Dysfunction and Chlorine ToxicityR21ES024027 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DARLEY-USMAR, VICTOR M, MATALON, SADIS · 2013 to 2014
$735k
NHLBI NIH HHS 5R01HL031197NIDDK NIH HHS 5R01 DK060065NIEHS NIH HHS 1 R21 ES025423 01NIEHS NIH HHS 5R21 ES024027 02
6 · The paper itself

Abstract

CFTR is a cAMP-activated chloride and bicarbonate channel that is critical for lung homeostasis. Decreases in CFTR expression have dire consequences in cystic fibrosis (CF) and have been suggested to be a component of the lung pathology in chronic obstructive pulmonary disease. Decreases or loss of channel function often lead to mucus stasis, chronic bacterial infections, and the accompanying chronic inflammatory responses that promote progressive lung destruction, and, eventually in CF, lung failure. Here we discuss CFTR's functional role airway surface liquid hydration and pH, in regulation of other channels such as the epithelial sodium channel, and in regulating inflammatory responses in the lung.

Indexed as

HomeostasisAnimalsCystic Fibrosis Transmembrane Conductance RegulatorHumansHydrogen-Ion ConcentrationLungPulmonary Disease, Chronic ObstructiveRespiratory InsufficiencyCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulatorchronic obstructive pulmonary diseasecystic fibrosisinflammatory responsesmucus obstructionoxidative stress

Identifiers

PMID25381027
PMCPMC4269691
OpenAlexW1986032412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.